This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
T3D | Ann: Change of Company Secretary & Registered Office | 01/03/19 | 1 | 448 | |||
|
|||||||
T3D | Ann: Appendix 4D and Half Year Financial Report | 14:43 | 0 | 177 | |||
|
|||||||
T3D | Ann: Loan Funding | 26/02/19 | 14 | 3.0K | |||
|
|||||||
T3D | Ann: Response to ASX Price and Volume Query | 25/02/19 | 0 | 258 | |||
|
|||||||
T3D | Ann: Appendix 4C - quarterly | 30/01/19 | 1 | 544 | |||
|
|||||||
T3D | Ann: Change of Director's Interest Notice x 3 | 19/12/18 | 0 | 208 | |||
|
|||||||
T3D | Ann: Appendix 3B | 18/12/18 | 0 | 150 | |||
|
|||||||
T3D | no attention to t3d. what a sham this has turned out to be. | 30/11/18 | 0 | 493 | |||
|
See All Discussions